FIELD: medicine.
SUBSTANCE: method involves administering selective modulator of steroid sex hormones being in particular compounds of general formula(I) and some quantity of steroid sex hormones precursor selected from a group composed from dehydroepiandrosterone, dehydroepiandrosterone sulfate, androst-5-en-3β,17β-diol and compounds in vivo transformable into one of cited precursors. Bisphosphonates combined with selective estrogen receptor modulators and/or steroid sex hormones precursor are additionally introduced for medically treating and/or inhibiting osteoporosis progress.
EFFECT: enhanced effectiveness of treatment; excluded adverse side effects.
41 cl, 13 dwg, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS OF TREATING AND/OR SUPPRESSING WEIGHT GROWTH | 2000 |
|
RU2519642C2 |
| METHOD OF MASS INCREASE TREATMENT AND/OR INHIITION | 2000 |
|
RU2327461C2 |
| METHOD FOR MASS INCREASE TREATMENT AND/OR INHIBITION | 2013 |
|
RU2636498C2 |
| ANDROST-5-ENE-3β,17β-DIOL-CONTAINING PHARMACEUTICAL COMPOSITIONS AND ITS USING | 1999 |
|
RU2221569C2 |
| FLUORINATED DERIVATIVES OF 4-AZASTEROID AS ANDROGEN RECEPTOR MODULATORS | 2003 |
|
RU2320670C2 |
| 16α-BROMO-3β-HYDROXY-5α-ANDROSTANE-17-ONE SEMIHYDRATE, METHOD FOR ITS PREPARING, PHARMACEUTICAL COMPOSITIONS, USING COMPOUNDS | 2000 |
|
RU2295534C2 |
| METHOD FOR PROPHYLAXIS AND TREATMENT OF ESTROGEN-DEPENDENT DISEASES AND DISORDERS | 1998 |
|
RU2214236C2 |
| HYDROXYMATAIRESINOL IN PREVENTING THE CANCER | 2000 |
|
RU2241453C2 |
| SUSTAINED RELEASE SYSTEMS AND LOW DOSES OF ANDROGENS, METHODS OF THEIR PREPARING AND METHOD OF TREATMENT USING THESE SYSTEMS | 1992 |
|
RU2142276C1 |
| APPLICATION OF SOPHORICOSIDE FOR PREPARING DRUGS | 2009 |
|
RU2454236C1 |
